Ultime notizie per Venator Materials (OTC:VNTRF) Azioni

Venator Materials PLC is a manufacturer and marketer of chemical products. Its products comprise a broad range of pigments and additives that bring color and vibrancy to buildings, protect and extend product life, and reduce energy consumption. The company market its products globally to a diversified group of industrial customers through two segments, Titanium Dioxide, which consists of its TiO2 business, and Performance Additives, which consist of functional additives, color pigments, timber treatment, and water treatment businesses. It derives a majority of its revenue from the Titanium Dioxide segment. The company's key product lines include TiO2, color pigments, functional additives, timber treatment, and water treatment products.

VENATOR MATERIALS PLC by Venator Materials PLC

Venator Materials PLC

Journey Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.24) by 25 percent. This is a 66.04 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $13.14 million which beat the analyst consensus estimate of $12.05 million by 9.00 percent. This is a 0.84 percent increase over sales of $13.03 million the same period last year.

Earnings

Earnings Beats

News

DERM

Journey Medical Q1 EPS $(0.18) Beats $(0.24) Estimate, Sales $13.14M Beat $12.05M Estimate

SHIM

Shimmick Q1 Adj. EPS $(0.22) Beats $(0.25) Estimate, Sales $122.00M Beat $94.35M Estimate

Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.69) by 24.64 percent. This is a 31.58 percent increase over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $15.36 million which beat the analyst consensus estimate of $14.95 million by 2.74 percent. This is a 24.01 percent decrease over sales of $20.21 million the same period last year.

ATER

Aterian Q1 EPS $(0.52) Beats $(0.69) Estimate, Sales $15.36M Beat $14.95M Estimate

Hawkins (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWKN#NASDAQ">HWKN</a>) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.73 by 6.85 percent. This is a 18.18 percent increase over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $245.32 million which beat the analyst consensus estimate of $230.69 million by 6.34 percent. This is a 10.00 percent increase over sales of $223.02 million the same period last year.

HWKN

Hawkins Q4 EPS $0.78 Beats $0.73 Estimate, Sales $245.32M Beat $230.69M Estimate

Azitra plans to dose first patient in a Phase 1/2 trial in the first half of 2025 for its precision dermatology candidate ATR04-484, designed for the treatment of EGFR inhibitor-associated rash

Biotech

Events

General

AZTR

Azitra To Present Phase 1/2 Study Of ATR04-484 For EGFR Inhibitor-Associated Rash

Guidance

SPIR

Spire Global Sees Q2 Adj EPS $(0.49)-$(0.42) vs $(0.47) Est; Sees Sales $18.000M-$20.000M vs $22.97M Est

SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.52) by 15.38 percent. This is a 90.74 percent increase over losses of $(4.75) per share from the same period last year. The company reported quarterly sales of $293.00 thousand which beat the analyst consensus estimate of $150.00 thousand by 95.33 percent.

SeaStar Medical Holding Q1 EPS $(0.44) Beats $(0.52) Estimate, Sales $293.00K Beat $150.00K Estimate

Fossil Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSL#NASDAQ">FOSL</a>) reported quarterly losses of $(0.10) per share. This is a 66.67 percent increase over losses of $(0.30) per share from the same period last year. The company reported $233.30 million in sales this quarter. This is a 8.47 percent decrease over sales of $254.90 million the same period last year.

FOSL

Fossil Group Q1 Adj. EPS $(0.10) Up From $(0.30) YoY, Sales $233.30M Down From $254.90M YoY

Under the STEP 2.0 contract, the Company is eligible for future task orders to design, build, integrate, and operate small satellite buses for next-generation space experiments

Contracts

Spire Global Wins 10-Year U.S. Space Force Contract With $237M Ceiling

Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.67) by 14.93 percent. This is a 45.28 percent decrease over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $23.90 million which beat the analyst consensus estimate of $22.68 million by 5.38 percent. This is a 6.96 percent decrease over sales of $25.69 million the same period last year.

Earnings Misses

Spire Global Q1 Adj. EPS $(0.77) Misses $(0.67) Estimate, Sales $23.90M Beat $22.68M Estimate

MRAI

Marpai Q1 EPS $(0.21) Up From $(0.46) YoY, Sales $5.42M Down From $7.38M YoY

Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $(0.17) by 223.53 percent. This is a 140.38 percent increase over losses of $(0.52) per share from the same period last year. The company reported quarterly sales of $18.45 million which beat the analyst consensus estimate of $13.74 million by 34.30 percent. This is a 31.57 percent increase over sales of $14.03 million the same period last year.

AYTU

Aytu BioPharma Q3 EPS $0.21 Beats $(0.17) Estimate, Sales $18.45M Beat $13.74M Estimate

Strata Skin Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSKN#NASDAQ">SSKN</a>) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 39.58 percent increase over losses of $(0.96) per share from the same period last year. The company reported quarterly sales of $6.81 million which missed the analyst consensus estimate of $7.28 million by 6.45 percent. This is a 0.86 percent increase over sales of $6.75 million the same period last year.

SSKN

Strata Skin Sciences Q1 EPS $(0.58) Misses $(0.52) Estimate, Sales $6.81M Miss $7.28M Estimate

Buybacks

Penske Automotive Group Increases Securities Repurchase Authorization By Additional $250M

Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 35.29 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $2.33 million which beat the analyst consensus estimate of $170.00 thousand by 1.27K percent. This is a 913.04 percent increase over sales of $230.00 thousand the same period last year.

CLSD

Clearside Biomedical Q1 EPS $(0.11), Inline, Sales $2.33M Beat $170.00K Estimate

Star Bulk Carriers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBLK#NASDAQ">SBLK</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.28) by 75 percent. This is a 108.05 percent decrease over earnings of $0.87 per share from the same period last year. The company reported quarterly sales of $230.65 million which beat the analyst consensus estimate of $173.06 million by 33.28 percent. This is a 11.08 percent decrease over sales of $259.39 million the same period last year.

SBLK

Star Bulk Carriers Q1 Adj. EPS $(0.07) Beats $(0.28) Estimate, Sales $230.65M Beat $173.06M Estimate

Dividends

Penske Automotive Group Increases Quarterly Dividend From $1.22 To $1.26 Per Share

Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) reported quarterly losses of $(0.84) per share. This is a 546.15 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $23.82 million which beat the analyst consensus estimate of $23.00 million by 3.56 percent. This is a 30.25 percent increase over sales of $18.29 million the same period last year.

Spruce Power Holding Corporation Class A Common Stock

SPRU

Spruce Power Holding Q1 EPS $(0.84) Down From $(0.13) YoY, Sales $23.82M Beat $23.00M Estimate

Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) is looking for Q4 Adj EPS of $0.96-$0.98 vs $0.95 analyst estimate. sees sales of $14.500 billion-$14.700 billion vs $14.58 billion analyst estimate.

CSCO

Cisco Systems Sees Q4 Adj EPS $0.96-$0.98 vs $0.95 Est; Sees Sales $14.500B-$14.700B vs $14.58B Est

Air Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIRI#AMEX">AIRI</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-15. Here's what investors need to know before the announcement.
Analysts estimate that Air Industries will report an earnings per share (EPS) of $0.05. 
The market awaits Air Industries's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.06, leading to a 2.77% drop in the share price on the subsequent day.
Here's a look at Air Industries's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.11</td>
<td>-0.02</td>
<td>-0.21</td>
<td>-0.12</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.17</td>
<td>-0.12</td>
<td>0.09</td>
<td>-0.21</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>-4.0%</td>
<td>3.0%</td>
<td>-21.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747253329_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Air Industries were trading at $3.59 as of May 13. Over the last 52-week period, shares are down 33.58%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/AIRI/earnings">To track all earnings releases for Air Industries visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Venator Materials

Notizie

Ultime notizie per Venator Materials (OTC:VNTRF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO